Obinutuzumab in two patients suffering from immune‐mediated thrombotic thrombocytopenic purpura intolerant to rituximab. Issue 10 (9th August 2019) - Robertz, Judith; Andres, Martin; Mansouri Taleghani, Behrouz; Koneth, Irene; Binet, Isabelle; Kremer Hovinga, Johanna A.